Search results
CTI BioPharma (CTIC) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCTI BioPharma (CTIC) delivered earnings and revenue surprises of -5% and 20.87%, respectively, for...
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
Benzinga via Yahoo Finance· 2 years agoSVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ: CTIC) with an Outperform rating and a...
CTI BioPharma: Q4 Earnings Snapshot
AP Finance via Yahoo Finance· 1 year agoSEATTLE (AP) — SEATTLE (AP) — CTI BioPharma Corp. (CTIC) on Monday reported a loss of $17.5 million in its fourth quarter. On a per-share basis, the Seattle-based company said it had a loss ...
12 Best Multibagger Stocks to Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss 12 best multibagger stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Multibagger Stocks...
10 Best Medical Stocks Under $5
Insider Monkey via Yahoo Finance· 2 years agoIn this piece, we will take a look at the ten best medical stocks under $5. If you want to jump ahead to the top five stocks in this list, then head on...
Stonepine Capital Management, LLC Acquires New Stake in Alimera Sciences Inc
GuruFocus.com via Yahoo Finance· 10 months agoStonepine Capital Management, LLC, a prominent investment firm, recently acquired a significant...
Incyte (INCY) Gets CRL for Jakafi Extended-Release Tablets
Zacks via Yahoo Finance· 1 year agoThe FDA issues a complete response letter to Incyte's (INCY) extended-release tablet formulation of...
